Bicycle Therapeutics plc
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-219.0M | $-169.0M | $-180.7M | $-112.7M | $-66.8M | $-51.0M | $-30.6M | $-21.8M |
| Depreciation & Amortization | $6.4M | $7.2M | $6.5M | $3.7M | $1.4M | $1.3M | $960.0K | $712.0K |
| Depreciation | — | — | $6.5M | $3.7M | $1.4M | $1.3M | $1.0M | $700.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $39.5M | $38.1M | $32.5M | $26.8M | $12.1M | $6.5M | $3.1M | $1.0M |
| Net Cash from Operating Activities | $-249.7M | $-164.7M | $-60.6M | $-86.1M | $-14.8M | $-17.8M | $-28.6M | $-26.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.4M | $1.2M | $2.9M | $19.0M | $2.0M | $1.2M | $1.6M | $1.2M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-2.4M | $-1.2M | $-2.9M | $-19.0M | $-2.0M | $-1.2M | $-1.6M | $-1.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-131.0K | $519.8M | $250.0M | $6.7M | $320.7M | $62.8M | $58.4M | $25.4M |
| Net Change in Cash | $-251.4M | $353.1M | $187.8M | $-99.5M | $302.7M | $43.9M | $28.7M | $-4.3M |
| Free Cash Flow | $-252.0M | $-166.0M | $-63.6M | $-105.1M | $-16.8M | $-19.0M | $-30.2M | $-27.3M |